Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry

American Journal of Clinical Pathology

Volumn 119, Issue 2, 2003, Pages 205-212

  Juco, Jonathan ^b   Holden, Jeannine T ^b   Mann, Karen P ^b   Kelley, Lloyd G ^b   Li, Shiyong ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Anaplastic large cell lymphoma; Anaplastic lymphoma kinase; Flow cytometric immunophenotyping

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD14 ANTIGEN; CD15 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD33 ANTIGEN; CD36 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MICROSOMAL AMINOPEPTIDASE; T LYMPHOCYTE ANTIGEN; PROTEIN TYROSINE KINASE; TUMOR ANTIGEN;

ADOLESCENT; ADULT; AGED; ANAPLASTIC LARGE CELL LYMPHOMA; ANTIGEN EXPRESSION; ARTICLE; ASPIRATION BIOPSY; BODY FLUID; CHILD; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GRANULOCYTIC SARCOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; PRIORITY JOURNAL; CHROMOSOME BANDING PATTERN; IMMUNOLOGY; LYMPH NODE; METABOLISM; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; CHILD; CHILD, PRESCHOOL; CHROMOSOME BANDING; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, LARGE-CELL, KI-1; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES;

EID: 85047687266     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/HEFL7KC435KFWEX8     Document Type: Article

References (26)

1. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848-858.
2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
3. Foss HD, Anagnostopoulos I, Araujo I, et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood. 1996;88:4005-4011.
4. Delsol G, Ralfkiaer E, Stein H, et al. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:230-235. World Health Organization Classification of Tumours.
5. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1995;263:1281-1284.
6. Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93:3913-3921.
7. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinicopathological findings and outcome. Blood. 1999;93:2697-2706.
8. Weiss LM, Picker LJ, Copenhaver CM, et al. Large-cell hematolymphoid neoplasms of uncertain lineage. Hum Pathol. 1988;19:967-973.
9. Carbone A, Gloghini A, Volpe R, et al. KP1 (CD68)-positive large cell lymphomas: a histopathologic and immunophenotypic characterization of 12 cases. Hum Pathol. 1993;24:886-896.
10. Simonitsch I, Panzer-Gruemayer ER, Ghali DW, et al. NPM/ALK gene fusion transcripts identify a distinct subgroup of null type Ki-1 positive anaplastic large cell lymphomas. Br J Haematol. 1996;92:866-871.
11. Popnikolov NK, Payne DA, Hudnall D, et al. CD13-positive anaplastic large cell lymphoma of T-cell origin: a diagnostic and histogenetic problem: a case report and review of the literature. Arch Pathol Lab Med. 2000;124:1804-1808.
12. Dunphy CH, Gardner LJ, Manes JL, et al. CD30+ anaplastic large cell lymphoma with aberrant expression of CD13: case report and review of the literature. J Clin Lab Anal. 2000;14:299-304.
13. Hsu SM, Raine L, Fanger H. Use of the avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577-580.
14. Falini B, Bigerna B, Fizzotti M, et al. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol. 1998;153:875-886.
15. Stein H, Foss HD, Durkop H, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96:3681-3695.
16. Meech SJ, McGavran L, Odom LF, et al. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion. Blood. 2001;98:1209-1216.
17. Sato N, Sato K, Yagi E, et al. Primary cutaneous Ki-1+ anaplastic large cell lymphoma: a morphologic, immunohistochemical and genetic study of an indolent case. J Dermatol. 1995;22:441-449.
18. Aoki M, Niimi Y, Takezaki S, et al. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis. Br J Dermatol. 2001;145:123-126.
19. Delsol G, Al Saati T, Gatter KC, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988;130:59-70.
20. Rubie H, Gladieff L, Robert A, et al. Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases. Med Pediatr Oncol. 1994;22:155-161.
21. Rimokh R, Magaud JP, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol. 1989;71:31-36.
22. Kaneko Y, Frizzera G, Edamura S, et al. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood. 1989;73:806-813.
23. Shiota M, Fujimoto J, Takenaga M, et al. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood. 1994;84:3648-3652.
24. Shiota M, Nakamura S, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood. 1995;86:1954-1960.
25. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997;89:1394-1404.
26. Trinei M, Lanfrancone L, Campo E, et al. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. Cancer Res. 2000;60:793-798.